Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pase II Study of Glucosamine With Chondroitin on Joint Symptoms Induced By Aromatase Inhibitors in Breast Cancer Patients

NCT00691678 is registered in ClinicalTrials.gov with Dawn L. Hershman as lead sponsor.

NCT NCT00691678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00691678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pase II Study of Glucosamine With Chondroitin on Joint Symptoms Induced By Aromatase Inhibitors in Breast Cancer Patients
Lead sponsor
Dawn L. Hershman
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
September 30, 2012
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, joint pain